- Home>
- Specialty Care>
- Oncology and Hematology>
- Editor's Picks
Oncology and Hematology Editor's Picks
Preserving Future Fertility in Women Who Undergo Cancer Treatment
- General Medicine
- Summary and Comment
- Subscription required
Investigators developed a protocol to identify malignant cells in cryopreserved ovarian tissue.
- By Robert W. Rebar, MD
- July 15, 2008
- Covering Hum Reprod 2008 May
Evaluating the Safety of Hemoglobin-Based Blood Substitutes
- Emergency Medicine
- Summary and Comment
- Subscription required
Use of cell-free hemoglobin-based blood substitutes increases risk for MI and death.
- By John A. Marx, MD, FAAEM, FACEP
- May 9, 2008
- Covering JAMA 2008 Apr 28
Cancer Incidence Among HIV-Infected Patients
- HIV/AIDS
- Summary and Comment
- Subscription required
Rates of several non–AIDS-defining cancers are higher among HIV-infected patients in two large U.S. cohorts than in the general population.
- By Sonia Nagy Chimienti, MD
- June 9, 2008
- Covering Ann Intern Med 2008 May 20
New Brain Tumor Therapies, New Recurrence Patterns
- Neurology
- Summary and Comment
- Free
This informative retrospective study confirms that bevacizumab is active against recurrent malignant gliomas but may alter recurrence patterns.
- By Amy A. Pruitt, MD
- May 6, 2008
- Covering Neurology 2008 Mar 4
Estrogen plus Progestin: Diagnostic Mammograms and Biopsies
- Women's Health
- Summary and Comment
- Subscription required
Use of E+P increased women’s likelihood of needing diagnostic breast imaging and breast biopsies.
- By Andrew M. Kaunitz, MD
- April 10, 2008
- Covering Arch Intern Med 2008 Feb 25
Comparing Treatments for Localized Prostate Cancer
- General Medicine
- Summary and Comment
- Subscription required
Remarkably, little evidence exists about the comparative benefits and harms of available treatment strategies.
- By Richard Saitz, MD, MPH, FACP, FASAM
- April 24, 2008
- Covering Ann Intern Med 2008 Mar 18
BRAF Mutations Exclude Lynch Syndrome
- Gastroenterology
- Summary and Comment
- Subscription required
Could testing MSI-positive tumors for BRAF mutations attenuate germline testing for mismatch-repair gene mutations and, thereby, simplify workups and lower costs?
- By Douglas K. Rex, MD
- March 21, 2008
- Covering Clin Gastroenterol Hepatol 2008 Feb
Flat Lesions Becoming More Prevalent in the U.S.
- Gastroenterology
- Summary and Comment
- Subscription required
Recently published data have highlighted the prevalence of flat and depressed lesions in the U.S. population and risk for high-grade dysplasia and invasive cancer that is associated with these lesions.
- By Douglas K. Rex, MD
- March 21, 2008
- Covering JAMA 2008 Mar 5
Hormone Therapy in Breast Cancer Survivors
- General Medicine
- Summary and Comment
- Subscription required
Hormone therapy in this population raises risk for recurrence.
- By Allan S. Brett, MD
- April 24, 2008
- Covering J Natl Cancer Inst 2008 Apr 2
How Safe Are OCs and Menopausal Hormone Therapy After Breast Cancer?
- Women's Health
- Summary and Comment
- Subscription required
Use of the pill or hormone therapy does not seem to increase risk for a second primary breast cancer.
- By Andrew M. Kaunitz, MD
- March 20, 2008
- Covering J Clin Oncol 2008 Feb 4
Read more Oncology and Hematology Editor's Picks articles >>